Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Collegium Pharmaceutical (COLL) Operating Margin (2016 - 2025)

Collegium Pharmaceutical has reported Operating Margin over the past 10 years, most recently at 29.57% for Q4 2025.

  • Quarterly results put Operating Margin at 29.57% for Q4 2025, up 863.0% from a year ago — trailing twelve months through Dec 2025 was 23.01% (down 1237.0% YoY), and the annual figure for FY2025 was 23.01%, down 389.0%.
  • Operating Margin for Q4 2025 was 29.57% at Collegium Pharmaceutical, roughly flat from 29.66% in the prior quarter.
  • Over the last five years, Operating Margin for COLL hit a ceiling of 437.62% in Q3 2024 and a floor of 275.52% in Q1 2022.
  • Median Operating Margin over the past 5 years was 20.36% (2021), compared with a mean of 23.22%.
  • Biggest five-year swings in Operating Margin: surged 40469bps in 2024 and later crashed -40797bps in 2025.
  • Collegium Pharmaceutical's Operating Margin stood at 89.02% in 2021, then surged by 110bps to 9.07% in 2022, then skyrocketed by 354bps to 41.2% in 2023, then plummeted by -49bps to 20.95% in 2024, then skyrocketed by 41bps to 29.57% in 2025.
  • The last three reported values for Operating Margin were 29.57% (Q4 2025), 29.66% (Q3 2025), and 18.67% (Q2 2025) per Business Quant data.